AETHLON MEDICAL INC AEMD

$2.17 -4.82% at last close

Recent SEC Filings

FormDescriptionFiledDocument
10-Q FORM 10-Q FOR JUN 2026 2026-08-13 View →
8-K CURRENT REPORT 2026-08-13 View →
8-K CURRENT REPORT 2026-07-31 View →
8-K CURRENT REPORT 2026-07-08 View →
4 Insider transaction 2026-07-01 View →
4 Insider transaction 2026-07-01 View →
4 Insider transaction 2026-07-01 View →
S-1 REGISTRATION STATEMENT 2026-06-22 View →
10-K FORM 10-K FOR MAR 2026 2026-06-10 View →
8-K CURRENT REPORT 2026-06-10 View →
8-K FORM 8-K 2026-06-04 View →
424B5 PROSPECTUS 2026-06-04 View →
4 Insider transaction 2026-04-21 View →
4 Insider transaction 2026-04-21 View →
4 Insider transaction 2026-04-21 View →
4 Insider transaction 2026-04-21 View →
4 Insider transaction 2026-04-01 View →
4 Insider transaction 2026-04-01 View →
4 Insider transaction 2026-04-01 View →
8-K FORM 8-K 2026-03-17 View →
8-K CURRENT REPORT 2026-02-23 View →
10-Q FORM 10-Q FOR DEC 2025 2026-02-12 View →
8-K CURRENT REPORT 2026-02-12 View →
8-K FORM 8-K 2026-01-26 View →
DEF 14A FORM DEF 14A 2026-01-16 View →
S-1 REGISTRATION STATEMENT 2026-01-07 View →
4 Insider transaction 2026-01-02 View →
4 Insider transaction 2026-01-02 View →
4 Insider transaction 2026-01-02 View →
S-3 FORM S-3 2025-12-23 View →
8-K FORM 8-K 2025-12-08 View →
10-Q FORM 10-Q FOR SEPT 2025 2025-11-12 View →
8-K FORM 8-K 2025-11-12 View →
8-K FORM 8-K 2025-11-06 View →
8-K FORM 8-K 2025-10-22 View →
8-K FORM 8-K 2025-10-16 View →
4 Insider transaction 2025-10-02 View →
4 Insider transaction 2025-10-02 View →
4 Insider transaction 2025-10-02 View →
8-K FORM 8-K 2025-09-12 View →

Filings are sourced directly from the SEC's EDGAR system. Annual reports (10-K) and quarterly reports (10-Q) carry the full financial statements; 8-K filings disclose material events between reports; Form 4 filings record insider purchases and sales.

Key Stats

Last Close
$2.17
Market Cap
$1.62 million
52-Week Range
$2.17 $137.00
Average Volume
600K shs

Data is delayed and provided for informational purposes only. Not investment advice. See our disclaimer.